Peggy Huang

993 total citations
17 papers, 769 citations indexed

About

Peggy Huang is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Peggy Huang has authored 17 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Infectious Diseases and 6 papers in Organic Chemistry. Recurrent topics in Peggy Huang's work include HIV/AIDS drug development and treatment (8 papers), Hepatitis C virus research (5 papers) and Chemical Synthesis and Analysis (3 papers). Peggy Huang is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Hepatitis C virus research (5 papers) and Chemical Synthesis and Analysis (3 papers). Peggy Huang collaborates with scholars based in United States, United Kingdom and Switzerland. Peggy Huang's co-authors include Elizabeth A. Craig, Rebecca Aron, Amy J. Andrew, John T. Randolph, Larry L. Klein, William Walter, Matthias Gautschi, Sabine Rospert, Wenping He and Akhteruzzaman Molla and has published in prestigious journals such as The Journal of Cell Biology, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Peggy Huang

17 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peggy Huang United States 11 470 153 128 123 99 17 769
Louise Thauvette Canada 11 222 0.5× 150 1.0× 187 1.5× 115 0.9× 65 0.7× 15 549
Gisele Tavares France 9 254 0.5× 101 0.7× 59 0.5× 74 0.6× 58 0.6× 11 601
Maria Chiara Nardi Italy 11 613 1.3× 130 0.8× 89 0.7× 49 0.4× 82 0.8× 12 787
Nilabh Chaudhary United States 15 1.2k 2.6× 73 0.5× 82 0.6× 49 0.4× 25 0.3× 21 1.5k
Bernard Bayard France 20 815 1.7× 26 0.2× 94 0.7× 60 0.5× 172 1.7× 44 1.1k
David L. Earnshaw United Kingdom 15 397 0.8× 57 0.4× 272 2.1× 86 0.7× 62 0.6× 21 849
B R Nodes United States 9 333 0.7× 46 0.3× 50 0.4× 121 1.0× 19 0.2× 9 481
Philippe Neuner Italy 11 475 1.0× 66 0.4× 60 0.5× 89 0.7× 78 0.8× 18 621
Jonathan St‐Germain Canada 18 609 1.3× 19 0.1× 65 0.5× 53 0.4× 26 0.3× 33 841
Marco Derudas United Kingdom 16 208 0.4× 37 0.2× 180 1.4× 255 2.1× 137 1.4× 28 588

Countries citing papers authored by Peggy Huang

Since Specialization
Citations

This map shows the geographic impact of Peggy Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peggy Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peggy Huang more than expected).

Fields of papers citing papers by Peggy Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peggy Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peggy Huang. The network helps show where Peggy Huang may publish in the future.

Co-authorship network of co-authors of Peggy Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Peggy Huang. A scholar is included among the top collaborators of Peggy Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peggy Huang. Peggy Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Randolph, John T., Peggy Huang, Rolf Wagner, et al.. (2013). High potency improvements to weak aryl uracil HCV polymerase inhibitor leads. Bioorganic & Medicinal Chemistry Letters. 23(15). 4367–4369. 5 indexed citations
2.
Huang, Peggy, et al.. (2013). Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mTORC1. The Journal of Cell Biology. 202(1). 53–69. 93 indexed citations
3.
Flentge, Charles A., John T. Randolph, Peggy Huang, et al.. (2009). Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs. Bioorganic & Medicinal Chemistry Letters. 19(18). 5444–5448. 9 indexed citations
4.
Randolph, John T., Charles A. Flentge, Peggy Huang, et al.. (2009). Synthesis and Biological Characterization of B-Ring Amino Analogues of Potent Benzothiadiazine Hepatitis C Virus Polymerase Inhibitors. Journal of Medicinal Chemistry. 52(10). 3174–3183. 34 indexed citations
5.
Randolph, John T., Xiaolin Zhang, Peggy Huang, et al.. (2008). Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(8). 2745–2750. 24 indexed citations
6.
Konstantinidis, Alex K., Paul L. Richardson, Rakesh Tripathi, et al.. (2007). Longer wavelength fluorescence resonance energy transfer depsipeptide substrates for hepatitis C virus NS3 protease. Analytical Biochemistry. 368(2). 156–167. 9 indexed citations
7.
Randolph, John T., Peggy Huang, David A. DeGoey, et al.. (2006). Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry. 14(12). 4035–4046. 10 indexed citations
8.
Craig, Elizabeth A., Peggy Huang, Rebecca Aron, & Amy J. Andrew. (2006). The diverse roles of J-proteins, the obligate Hsp70 co-chaperone. Reviews of physiology, biochemistry and pharmacology. 156. 1–21. 168 indexed citations
9.
Lynch, J.A., et al.. (2005). Titanium Tetraisopropoxide Catalyzed Synthesis of Base‐Sensitive Cyanoguanidine Analogs. Synthetic Communications. 35(1). 1–7. 13 indexed citations
10.
Huang, Peggy, Matthias Gautschi, William Walter, Sabine Rospert, & Elizabeth A. Craig. (2005). The Hsp70 Ssz1 modulates the function of the ribosome-associated J-protein Zuo1. Nature Structural & Molecular Biology. 12(6). 497–504. 101 indexed citations
11.
Huang, Peggy, John T. Randolph, Larry L. Klein, et al.. (2004). Synthesis and antiviral activity of P1′ arylsulfonamide azacyclic urea HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(15). 4075–4078. 10 indexed citations
12.
Lu, Liangjun, Edward Tam, Kent D. Stewart, et al.. (2004). Mutations Conferring Resistance to a Potent Hepatitis C Virus Serine Protease Inhibitor In Vitro. Antimicrobial Agents and Chemotherapy. 48(6). 2260–2266. 140 indexed citations
13.
Pfund, Christine, et al.. (2001). Divergent Functional Properties of the Ribosome-Associated Molecular Chaperone Ssb Compared with Other Hsp70s. Molecular Biology of the Cell. 12(12). 3773–3782. 57 indexed citations
14.
Quan, Mimi L., Ann Y. Liauw, Christopher D. Ellis, et al.. (1999). Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 1. Journal of Medicinal Chemistry. 42(15). 2752–2759. 64 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026